Literature DB >> 11754896

Clinical and experimental observation of glistening in acrylic intraocular lenses.

A Miyata1, N Uchida, K Nakajima, S Yaguchi.   

Abstract

PURPOSE: To determine whether or not glistening particles in implanted acrylic intraocular lenses (IOL) increase with the passage of time.
METHODS: Prospective clinical study: Glistenings were evaluated in 31 patients (49 eyes) with implanted acrylic IOL, the emphasis being on when glistening first became evident and subsequent changes in the number of glistening particles. EXPERIMENT: IOLs were monitored for any changes that occurred with the passage of time as they were immersed first in a 50 degrees C saline solution and then in another saline solution with a temperature of 35 degrees C.
RESULTS: Prospective clinical study: Glistening phenomenon was observed in 28 IOLs (57%) 2 to 16 months after implantation (mean = 6.6 months). Glistenings reached their peak in number within a few months of formation in all cases, showing no further increase thereafter. EXPERIMENT: Glistening particles first appeared on the 10th day of the experiment in sizes ranging from 3 to 10 microm in diameter. They remained at the same level for the next 60 days without showing any increase.
CONCLUSIONS: Glistening formation in acrylic IOLs was found to stabilize within a few months after appearance. The method of our experiment proved reliable in producing, in a relatively short period of time, glistening similar to that found in patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754896     DOI: 10.1016/s0021-5155(01)00429-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  15 in total

1.  Intraoperative clouding of a posterior chamber intraocular lens.

Authors:  Pallavi Tyagi; Nimish Shah; Mohamad Jabir
Journal:  Int Ophthalmol       Date:  2011-12-03       Impact factor: 2.031

2.  Comparison of pseudophakic retinal straylight in spherical/aspherical and hydrophobic/hydrophilic intraocular lens.

Authors:  Yong Tang; Hui Song; Jing Chen; Xin Tang
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

3.  Preoperative opacification of acrylic intraocular lenses in storage.

Authors:  C M Pratt; S Barton; E McGonigle; M Kishi; P J S Foot
Journal:  J Mater Sci Mater Med       Date:  2007-04       Impact factor: 3.896

4.  Effects of intraocular lens glistenings on visual function: a prospective study and presentation of a new glistenings grading methodology.

Authors:  Nick Stanojcic; David P S O'Brart; Nick Maycock; Chistopher C Hull
Journal:  BMJ Open Ophthalmol       Date:  2019-04-01

Review 5.  Biomaterial Influence on Intraocular Lens Performance: An Overview.

Authors:  Cari Pérez-Vives
Journal:  J Ophthalmol       Date:  2018-03-15       Impact factor: 1.909

6.  Steam-like clouding observed on anterior surface of intraocular lens developed soon after implantation.

Authors:  Ichiro Ota; Goichiro Miyake; Tetsu Asami; Kensaku Miyake
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-15

7.  Evaluation of in vitro glistening formation in hydrophobic acrylic intraocular lenses.

Authors:  Brett E Thomes; Thomas A Callaghan
Journal:  Clin Ophthalmol       Date:  2013-07-25

8.  Decreased visual acuity resulting from glistening and sub-surface nano-glistening formation in intraocular lenses: A retrospective analysis of 5 cases.

Authors:  Hiroyuki Matsushima; Mayumi Nagata; Yoko Katsuki; Ichiro Ota; Kensaku Miyake; George H H Beiko; Andrzej Grzybowski
Journal:  Saudi J Ophthalmol       Date:  2015-07-29

9.  Long-term clinical results and scanning electron microscopic analysis of the aspheric, hydrophobic, acrylic intraocular lens CT LUCIA 611P(Y).

Authors:  Andreas F Borkenstein; Eva-Maria Borkenstein
Journal:  Clin Ophthalmol       Date:  2018-07-05

10.  Glistening formation in a new hydrophobic acrylic intraocular lens.

Authors:  Timur M Yildirim; Hui Fang; Sonja K Schickhardt; Qiang Wang; Patrick R Merz; Gerd U Auffarth
Journal:  BMC Ophthalmol       Date:  2020-05-06       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.